ORGN is no longer listed. Its last trade on record was Jul 15, 2026. The price and figures on this page are from its last trading day and final filings, and are no longer updated.
Latest Ratios: P/E Ratio N/A · EV/EBITDA N/A · ROE N/A. (2019–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | — | $31M | $183M | $119M | $655M | $685M | $665M | — |
| Enterprise Value | — | $26M | $137M | $54M | $556M | $646M | $673M | — |
| P/E Ratio → | — | — | — | 5.02 | 8.34 | 16.27 | — | — |
| P/S Ratio | — | 1.66 | 5.86 | 4.14 | — | — | — | — |
| P/B Ratio | — | 0.30 | 0.54 | 0.28 | 1.74 | 2.26 | 5405.27 | — |
| P/FCF | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.38 | 4.37 | 1.86 | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | 57.71 | — |
| EV / EBIT | — | — | — | 2.35 | 7.08 | 14.37 | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | 2.9% | 1.3% | 18.1% | — | — | — | — |
| Operating Margin | — | -335.4% | -271.3% | -190.5% | — | — | — | — |
| Net Profit Margin | — | -1319.6% | -267.6% | 82.6% | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | — | -112.8% | -22.0% | 6.0% | 23.1% | 27.7% | -210.0% | -1.7% |
| ROA | — | -93.2% | -19.9% | 5.0% | 15.6% | 15.1% | -63.6% | -1.0% |
| ROIC | — | -24.4% | -19.6% | -13.0% | -10.8% | -14.9% | 37.4% | — |
| ROCE | — | -25.7% | -20.8% | -11.9% | -7.9% | -9.9% | 26.3% | 24.5% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | 0.27 | 0.03 | 0.02 | 0.02 | 0.02 | 75.83 | 0.38 |
| Debt / EBITDA | — | — | — | — | — | — | 0.80 | 0.94 |
| Net Debt / Equity | — | -0.05 | -0.14 | -0.16 | -0.26 | -0.13 | 65.19 | 0.28 |
| Net Debt / EBITDA | — | — | — | — | — | — | 0.69 | 0.68 |
| Debt / FCF | — | — | — | — | — | — | — | — |
| Interest Coverage | — | -2024.02 | -222.80 | 174.37 | — | 15.83 | -32.79 | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | — | 2.83 | 11.09 | 14.55 | 16.73 | 107.76 | 0.26 | 1.92 |
| Quick Ratio | — | 2.81 | 11.02 | 14.48 | 16.73 | 107.76 | 0.26 | 1.92 |
| Cash Ratio | — | 1.87 | 8.20 | 12.30 | 16.32 | 106.07 | 0.17 | 1.18 |
| Asset Turnover | — | 0.12 | 0.08 | 0.06 | — | — | — | — |
| Inventory Turnover | — | 26.87 | 35.64 | 25.87 | — | — | — | — |
| Days Sales Outstanding | — | 292.24 | 253.26 | 248.07 | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | 19.9% | 12.0% | 6.1% | — | — |
| FCF Yield | — | — | — | — | — | — | — | — |
| Buyback Yield | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Total Shareholder Yield | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Shares Outstanding | — | $5M | $5M | $5M | $5M | $4M | $2M | $1M |
Includes 30+ ratios · 7 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ORGN stock.
Based on historical data, Origin Materials, Inc. is trading at valuation metrics that vary. Compare with industry peers and growth rates for a complete picture.
Key Metrics
Top Statement Risk
Capital exhaustion and dilution
Metrics are mathematically derived from official filings.
Market Pricing Reflects Distressed Outlook
According to current market data, ORGN trades at a P/S multiple of 0.25, which, when compared to historical levels and specialty chemical peers, suggests that investors have largely abandoned growth expectations in favor of pricing the company based on its remaining tangible asset base.
The depressed P/S ratio indicates that the market is heavily discounting the company's future revenue potential, likely due to the persistent failure to scale commercial operations. This valuation level implies that the market views the current business model as a distressed asset rather than a growth-stage technology firm.
Capital Compounding Remains Deeply Negative
As reported in financial statements, the company's ROIC has remained consistently negative, reaching -13.5% in 2026Q1, which highlights a structural inability to generate returns on invested capital that exceed the cost of funding its capital-intensive thermochemical conversion infrastructure.
The persistent decay in ROIC suggests that the capital deployed into the Sarnia facility and other projects has failed to produce the expected economic value. Investors should monitor whether management can pivot to a less capital-intensive licensing model to reverse this trend, as current returns are fundamentally unsustainable.
Working Capital Cycles Indicate Friction
Based on quarterly data, the cash conversion cycle has ballooned to 1,980 days in 2026Q1, a significant deterioration from historical norms that reflects severe operational inefficiencies and a lack of meaningful product throughput compared to the company's peers in the industrial materials sector.
This extreme CCC figure suggests that the company is struggling to manage its inventory and receivables effectively, likely due to the lack of a stable, recurring customer base. The inability to turn over assets efficiently implies that the current operational setup is not yet optimized for commercial-scale production.
Liquidity Runway Narrows Under Pressure
As indicated by the company's latest balance sheet, the current ratio has declined to 2.66 in 2026Q1, which, while appearing superficially healthy, masks a rapid depletion of cash reserves that leaves the firm vulnerable to further operational setbacks or unexpected capital requirements.
While the current ratio remains above parity, the absolute cash balance is insufficient to support the company's high fixed-cost structure for an extended period. This liquidity position warrants close monitoring, as the firm may be forced to seek dilutive financing if it cannot achieve self-sustaining cash flow soon.
Misapplied Focus on P/S Multiples
Investors frequently misapply the Price-to-Sales ratio to ORGN, which obscures the reality that the company's current revenue is largely transactional and non-recurring, making it a poor proxy for the long-term value of its proprietary thermochemical conversion intellectual property.
Instead of relying on P/S, analysts should focus on the 'burn-to-milestone' ratio, which measures the cash required to reach the next technical or commercial inflection point. Using P/S in this context ignores the high probability of equity dilution, which is the primary risk factor for shareholders in this specific business model.